Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer

Por Golden, Daniel I, Lipson, Jafi A, Telli, Melinda L, Ford, James M, Rubin, Daniel L
Publicado em 2013

Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies: Are Clinicians Responding Optimally?

Por Yoon, Geoffrey J., Telli, Melinda L., Kao, David P., Matsuda, Kelly Y., Carlson, Robert W., Witteles, Ronald M.
Publicado em 2010

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured dissem...

Por Deng, Glenn, Krishnakumar, Sujatha, Powell, Ashley A, Zhang, Haiyu, Mindrinos, Michael N, Telli, Melinda L, Davis, Ronald W, Jeffrey, Stefanie S
Publicado em 2014

Acute, Unilateral Breast Toxicity From Gemcitabine in the Setting of Thoracic Inlet Obstruction

Por Weiskopf, Kipp, Creighton, David, Lew, Thomas, Caswell, Jennifer L., Ouyang, David, Shah, Arpeet T., Hofmann, Lawrence V., Neal, Joel W., Telli, Melinda L.
Publicado no J Oncol Pract (2016)

Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer

Por Palesh, Oxana, Peppone, Luke, Innominato, Pasquale F, Janelsins, Michelle, Jeong, Monica, Sprod, Lisa, Savard, Josee, Rotatori, Max, Kesler, Shelli, Telli, Melinda, Mustian, Karen
Publicado em 2012

Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California

Por Gomez, Scarlett Lin, Lichtensztajn, Daphne, Kurian, Allison W., Telli, Melinda L., Chang, Ellen T., Keegan, Theresa H. M., Glaser, Sally L., Clarke, Christina A.
Publicado no J Clin Oncol (2010)

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

Por Telli, Melinda L., Chang, Ellen T., Kurian, Allison W., Keegan, Theresa H. M., McClure, Laura A., Lichtensztajn, Daphne, Ford, James M., Gomez, Scarlett L.
Publicado no Breast Cancer Res Treat (2010)

Breast Cancer Phenotype in Women with TP53 Germline Mutations: a Li Fraumeni Syndrome Consortium Effort

Por Masciari, Serena, Dillon, Deborah A., Rath, Michelle, Robson, Mark, Weitzel, Jeffrey N., Balmana, Judith, Gruber, Stephen B., Ford, James M., Euhus, David, Lebensohn, Alexandra, Telli, Melinda, Pochebit, Stephen M., Lypas, Georgios, Garber, Judy E
Publicado em 2012

Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Recapitulate the Predilection of Breast Cancer Patients to Doxorubicin–Induced Cardiotoxicity

Por Burridge, Paul W., Li, Yong Fuga, Matsa, Elena, Wu, Haodi, Ong, Sang–Ging, Sharma, Arun, Holmström, Alexandra, Chang, Alex C., Coronado, Michael J., Ebert, Antje D., Knowles, Joshua W., Telli, Melinda L., Witteles, Ronald M., Blau, Helen M., Bernstein, Daniel, Altman, Russ B., Wu, Joseph C.
Publicado no Nat Med (2016)

Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition

Por Zhang, Haiyu, Cohen, Adam L, Krishnakumar, Sujatha, Wapnir, Irene L, Veeriah, Selvaraju, Deng, Glenn, Coram, Marc A, Piskun, Caroline M, Longacre, Teri A, Herrler, Michael, Frimannsson, Daniel O, Telli, Melinda L, Dirbas, Frederick M, Matin, AC, Dairkee, Shanaz H, Larijani, Banafshe, Glinsky, Gennadi V, Bild, Andrea H, Jeffrey, Stefanie S
Publicado em 2014

Genomic complexity profiling reveals that HORMAD1 overexpression contributes to homologous recombination deficiency in triple-negative breast cancers

Por Watkins, Johnathan, Weekes, Daniel, Shah, Vandna, Gazinska, Patrycja, Joshi, Shalaka, Sidhu, Bhavna, Gillett, Cheryl, Pinder, Sarah, Vanoli, Fabio, Jasin, Maria, Mayrhofer, Markus, Isaksson, Anders, Cheang, Maggie C.U., Mirza, Hasan, Frankum, Jessica, Lord, Christopher J., Ashworth, Alan, Vinayak, Shaveta, Ford, James M., Telli, Melinda L., Grigoriadis, Anita, Tutt, Andrew N.J.
Publicado no Cancer Discov (2015)

Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines

Por Powell, Ashley A., Talasaz, AmirAli H., Zhang, Haiyu, Coram, Marc A., Reddy, Anupama, Deng, Glenn, Telli, Melinda L., Advani, Ranjana H., Carlson, Robert W., Mollick, Joseph A., Sheth, Shruti, Kurian, Allison W., Ford, James M., Stockdale, Frank E., Quake, Stephen R., Pease, R. Fabian, Mindrinos, Michael N., Bhanot, Gyan, Dairkee, Shanaz H., Davis, Ronald W., Jeffrey, Stefanie S.
Publicado em 2012

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based M...

Por Telli, Melinda L., Jensen, Kristin C., Vinayak, Shaveta, Kurian, Allison W., Lipson, Jafi A., Flaherty, Patrick J., Timms, Kirsten, Abkevich, Victor, Schackmann, Elizabeth A., Wapnir, Irene L., Carlson, Robert W., Chang, Pei-Jen, Sparano, Joseph A., Head, Bobbie, Goldstein, Lori J., Haley, Barbara, Dakhil, Shaker R., Reid, Julia E., Hartman, Anne-Renee, Manola, Judith, Ford, James M.
Publicado no J Clin Oncol (2015)